Literature DB >> 2034050

MRI-assisted radiation therapy planning of brain tumors--clinical experiences in 17 patients.

M Just1, H P Rösler, H P Higer, J Kutzner, M Thelen.   

Abstract

A new and simple method for precise determination of lateral opposed treatment portals was developed and used in 17 patients. Compared to CT, MRI led to significant changes of portals in 59% (10/17) of cases. Individual shielding blocks could be precisely designed by use of our new method. MRI is the procedure of choice in local radiation therapy planning of brain tumors.

Entities:  

Mesh：

Year:  1991        PMID： 2034050     DOI： 10.1016/0730-725x(91)90007-9

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN： 0730-725X            Impact factor:   2.546


  6 in total

1.  In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models.

Authors:  Cindy Leten; Tom Struys; Tom Dresselaers; Uwe Himmelreich
Journal:  J Neurooncol       Date:  2014-07-03       Impact factor: 4.130

2.  [A simple method for transposing MRI information to simulation films. Technical note].

Authors:  W Wagner; K Ostkamp; U Niewöhner-Desbordes
Journal:  Strahlenther Onkol       Date:  2000-05       Impact factor: 3.621

Review 3.  MRI-only treatment planning: benefits and challenges.

Authors:  Amir M Owrangi; Peter B Greer; Carri K Glide-Hurst
Journal:  Phys Med Biol       Date:  2018-02-26       Impact factor: 3.609

4.  Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography.

Authors:  A Fiorentino; R Caivano; P Pedicini; V Fusco
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

5.  Using synthetic CT for partial brain radiation therapy: Impact on image guidance.

Authors:  Eric D Morris; Ryan G Price; Joshua Kim; Lonni Schultz; M Salim Siddiqui; Indrin Chetty; Carri Glide-Hurst
Journal:  Pract Radiat Oncol       Date:  2018-04-06

6.  Multimodality image fusion in dose escalation studies of brain tumors.

Authors:  D Rajasekar; N R Datta; R K Gupta; P K Pradhan; S Ayyagari
Journal:  J Appl Clin Med Phys       Date:  2003       Impact factor: 2.102
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.